Researchers in Cincinnati and Louisville report that immunosuppressive risks associated with facial transplantation may be lower than thought, possibly making the procedure a safer option for people who have suffered severe facial injuries.
Do you remember exactly where you were when you learned of the Sept. 11 terrorist attacks? Your answer is probably yes, and researchers are beginning to understand why we remember events that carry negative emotional weight.
Men may be more willing than women to sacrifice achievement goals for a romantic relationship, according to a new study by Catherine Mosher of Duke Medical Center and Sharon Danoff-Burg from the University of Albany.
A novel software application will help engineers and planners select the most efficient and site specific methods of controlling the amount of pollutants that enter the receiving waters through stormwater runoff.
UK PM Gordon Brown visited a health clinic this morning as new figures showed the NHS to be on an improved financial footing.
Not everyone needs a genetic test before taking the cancer drug irinotecan, and the U.S. Food and Drug Administration should modify its prescription guidelines to say so, according to researchers at the University of North Carolina at Chapel Hill.
A new study suggests that an experimental drug being tested for the treatment of multiple sclerosis and to prevent organ rejection might also help people with certain deadly forms of chronic and acute leukemia.
Researchers may be able to tinker with a single amino acid of an enzyme that helps viruses multiply to render them harmless, according to molecular biologists who say the discovery could pave the way for a fast and cheap method of making vaccines.
Patients with a particular version of the UGT1A1 gene are at greater risk of neutropenia, a shortage of certain white blood cells, if they are taking medium or high doses of the anticancer drug irinotecan.
Researchers have identified a gene, known as OGR1, that suppresses prostate cancer metastasis in mice.